Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Molecular Point-of-Care Testing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Polymerase Chain Reaction (PCR) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Molecular Point-of-Care Testing include Roche Molecular Diagnostics, Salignostics, Saw Diagnostics, Siemens Healthineer, Sona Nanotech, T2 Biosystems, Talis Biomedical, Thermo Fisher Scientific Inc. and Veramarx, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Molecular point-of-care (POC) testing is a type of diagnostic testing that uses nucleic acid amplification techniques such as polymerase chain reaction (PCR) to rapidly detect the presence of specific genetic material, such as DNA or RNA, directly in patient samples.
This report aims to provide a comprehensive presentation of the global market for Molecular Point-of-Care Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Point-of-Care Testing. This report contains market size and forecasts of Molecular Point-of-Care Testing in global, including the following market information:
Global Molecular Point-of-Care Testing Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Molecular Point-of-Care Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Point-of-Care Testing Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Molecular Point-of-Care Testing Market Segment Percentages, by Type, 2022 (%)
Polymerase Chain Reaction (PCR)
Loop-mediated Isothermal Amplification (LAMP)
Nucleic Acid Sequence-based Amplification (NASBA)
Global Molecular Point-of-Care Testing Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Molecular Point-of-Care Testing Market Segment Percentages, by Application, 2022 (%)
Infectious Diseases
Genetic Disorders
Pregnancy Testing
Diagnosis of Cancer
Pharmacogenomics
Global Molecular Point-of-Care Testing Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Molecular Point-of-Care Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Point-of-Care Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Molecular Point-of-Care Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche Molecular Diagnostics
Salignostics
Saw Diagnostics
Siemens Healthineer
Sona Nanotech
T2 Biosystems
Talis Biomedical
Thermo Fisher Scientific Inc.
Veramarx
XCR Diagnostics
Zhejiang Orient Gene Biotech
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Point-of-Care Testing, market overview.
Chapter 2: Global Molecular Point-of-Care Testing market size in revenue.
Chapter 3: Detailed analysis of Molecular Point-of-Care Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Point-of-Care Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Molecular Point-of-Care Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Point-of-Care Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Point-of-Care Testing Overall Market Size
2.1 Global Molecular Point-of-Care Testing Market Size: 2022 VS 2029
2.2 Global Molecular Point-of-Care Testing Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Molecular Point-of-Care Testing Players in Global Market
3.2 Top Global Molecular Point-of-Care Testing Companies Ranked by Revenue
3.3 Global Molecular Point-of-Care Testing Revenue by Companies
3.4 Top 3 and Top 5 Molecular Point-of-Care Testing Companies in Global Market, by Revenue in 2022
3.5 Global Companies Molecular Point-of-Care Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Molecular Point-of-Care Testing Players in Global Market
3.6.1 List of Global Tier 1 Molecular Point-of-Care Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Molecular Point-of-Care Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Molecular Point-of-Care Testing Market Size Markets, 2022 & 2029
4.1.2 Polymerase Chain Reaction (PCR)
4.1.3 Loop-mediated Isothermal Amplification (LAMP)
4.1.4 Nucleic Acid Sequence-based Amplification (NASBA)
4.2 By Type - Global Molecular Point-of-Care Testing Revenue & Forecasts
4.2.1 By Type - Global Molecular Point-of-Care Testing Revenue, 2018-2023
4.2.2 By Type - Global Molecular Point-of-Care Testing Revenue, 2024-2029
4.2.3 By Type - Global Molecular Point-of-Care Testing Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Molecular Point-of-Care Testing Market Size, 2022 & 2029
5.1.2 Infectious Diseases
5.1.3 Genetic Disorders
5.1.4 Pregnancy Testing
5.1.5 Diagnosis of Cancer
5.1.6 Pharmacogenomics
5.2 By Application - Global Molecular Point-of-Care Testing Revenue & Forecasts
5.2.1 By Application - Global Molecular Point-of-Care Testing Revenue, 2018-2023
5.2.2 By Application - Global Molecular Point-of-Care Testing Revenue, 2024-2029
5.2.3 By Application - Global Molecular Point-of-Care Testing Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Molecular Point-of-Care Testing Market Size, 2022 & 2029
6.2 By Region - Global Molecular Point-of-Care Testing Revenue & Forecasts
6.2.1 By Region - Global Molecular Point-of-Care Testing Revenue, 2018-2023
6.2.2 By Region - Global Molecular Point-of-Care Testing Revenue, 2024-2029
6.2.3 By Region - Global Molecular Point-of-Care Testing Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Molecular Point-of-Care Testing Revenue, 2018-2029
6.3.2 US Molecular Point-of-Care Testing Market Size, 2018-2029
6.3.3 Canada Molecular Point-of-Care Testing Market Size, 2018-2029
6.3.4 Mexico Molecular Point-of-Care Testing Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Molecular Point-of-Care Testing Revenue, 2018-2029
6.4.2 Germany Molecular Point-of-Care Testing Market Size, 2018-2029
6.4.3 France Molecular Point-of-Care Testing Market Size, 2018-2029
6.4.4 U.K. Molecular Point-of-Care Testing Market Size, 2018-2029
6.4.5 Italy Molecular Point-of-Care Testing Market Size, 2018-2029
6.4.6 Russia Molecular Point-of-Care Testing Market Size, 2018-2029
6.4.7 Nordic Countries Molecular Point-of-Care Testing Market Size, 2018-2029
6.4.8 Benelux Molecular Point-of-Care Testing Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Molecular Point-of-Care Testing Revenue, 2018-2029
6.5.2 China Molecular Point-of-Care Testing Market Size, 2018-2029
6.5.3 Japan Molecular Point-of-Care Testing Market Size, 2018-2029
6.5.4 South Korea Molecular Point-of-Care Testing Market Size, 2018-2029
6.5.5 Southeast Asia Molecular Point-of-Care Testing Market Size, 2018-2029
6.5.6 India Molecular Point-of-Care Testing Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Molecular Point-of-Care Testing Revenue, 2018-2029
6.6.2 Brazil Molecular Point-of-Care Testing Market Size, 2018-2029
6.6.3 Argentina Molecular Point-of-Care Testing Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Molecular Point-of-Care Testing Revenue, 2018-2029
6.7.2 Turkey Molecular Point-of-Care Testing Market Size, 2018-2029
6.7.3 Israel Molecular Point-of-Care Testing Market Size, 2018-2029
6.7.4 Saudi Arabia Molecular Point-of-Care Testing Market Size, 2018-2029
6.7.5 UAE Molecular Point-of-Care Testing Market Size, 2018-2029
7 Molecular Point-of-Care Testing Companies Profiles
7.1 Roche Molecular Diagnostics
7.1.1 Roche Molecular Diagnostics Company Summary
7.1.2 Roche Molecular Diagnostics Business Overview
7.1.3 Roche Molecular Diagnostics Molecular Point-of-Care Testing Major Product Offerings
7.1.4 Roche Molecular Diagnostics Molecular Point-of-Care Testing Revenue in Global Market (2018-2023)
7.1.5 Roche Molecular Diagnostics Key News & Latest Developments
7.2 Salignostics
7.2.1 Salignostics Company Summary
7.2.2 Salignostics Business Overview
7.2.3 Salignostics Molecular Point-of-Care Testing Major Product Offerings
7.2.4 Salignostics Molecular Point-of-Care Testing Revenue in Global Market (2018-2023)
7.2.5 Salignostics Key News & Latest Developments
7.3 Saw Diagnostics
7.3.1 Saw Diagnostics Company Summary
7.3.2 Saw Diagnostics Business Overview
7.3.3 Saw Diagnostics Molecular Point-of-Care Testing Major Product Offerings
7.3.4 Saw Diagnostics Molecular Point-of-Care Testing Revenue in Global Market (2018-2023)
7.3.5 Saw Diagnostics Key News & Latest Developments
7.4 Siemens Healthineer
7.4.1 Siemens Healthineer Company Summary
7.4.2 Siemens Healthineer Business Overview
7.4.3 Siemens Healthineer Molecular Point-of-Care Testing Major Product Offerings
7.4.4 Siemens Healthineer Molecular Point-of-Care Testing Revenue in Global Market (2018-2023)
7.4.5 Siemens Healthineer Key News & Latest Developments
7.5 Sona Nanotech
7.5.1 Sona Nanotech Company Summary
7.5.2 Sona Nanotech Business Overview
7.5.3 Sona Nanotech Molecular Point-of-Care Testing Major Product Offerings
7.5.4 Sona Nanotech Molecular Point-of-Care Testing Revenue in Global Market (2018-2023)
7.5.5 Sona Nanotech Key News & Latest Developments
7.6 T2 Biosystems
7.6.1 T2 Biosystems Company Summary
7.6.2 T2 Biosystems Business Overview
7.6.3 T2 Biosystems Molecular Point-of-Care Testing Major Product Offerings
7.6.4 T2 Biosystems Molecular Point-of-Care Testing Revenue in Global Market (2018-2023)
7.6.5 T2 Biosystems Key News & Latest Developments
7.7 Talis Biomedical
7.7.1 Talis Biomedical Company Summary
7.7.2 Talis Biomedical Business Overview
7.7.3 Talis Biomedical Molecular Point-of-Care Testing Major Product Offerings
7.7.4 Talis Biomedical Molecular Point-of-Care Testing Revenue in Global Market (2018-2023)
7.7.5 Talis Biomedical Key News & Latest Developments
7.8 Thermo Fisher Scientific Inc.
7.8.1 Thermo Fisher Scientific Inc. Company Summary
7.8.2 Thermo Fisher Scientific Inc. Business Overview
7.8.3 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Major Product Offerings
7.8.4 Thermo Fisher Scientific Inc. Molecular Point-of-Care Testing Revenue in Global Market (2018-2023)
7.8.5 Thermo Fisher Scientific Inc. Key News & Latest Developments
7.9 Veramarx
7.9.1 Veramarx Company Summary
7.9.2 Veramarx Business Overview
7.9.3 Veramarx Molecular Point-of-Care Testing Major Product Offerings
7.9.4 Veramarx Molecular Point-of-Care Testing Revenue in Global Market (2018-2023)
7.9.5 Veramarx Key News & Latest Developments
7.10 XCR Diagnostics
7.10.1 XCR Diagnostics Company Summary
7.10.2 XCR Diagnostics Business Overview
7.10.3 XCR Diagnostics Molecular Point-of-Care Testing Major Product Offerings
7.10.4 XCR Diagnostics Molecular Point-of-Care Testing Revenue in Global Market (2018-2023)
7.10.5 XCR Diagnostics Key News & Latest Developments
7.11 Zhejiang Orient Gene Biotech
7.11.1 Zhejiang Orient Gene Biotech Company Summary
7.11.2 Zhejiang Orient Gene Biotech Business Overview
7.11.3 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Major Product Offerings
7.11.4 Zhejiang Orient Gene Biotech Molecular Point-of-Care Testing Revenue in Global Market (2018-2023)
7.11.5 Zhejiang Orient Gene Biotech Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
